Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 0 | 0 | 0 | 6,169 |
| Gross Profit | N/A | N/A | 0 | N/A | 6,169 |
| Operating Expenses | 26,843 | 32,030 | 34,566 | 21,132 | 31,551 |
| Operating Income | -26,843 | -32,030 | -34,566 | -21,132 | -25,382 |
| Interest Expense | 111 | 121 | 0 | 0 | 0 |
| Other Income | 2,325 | 2,081 | 19,415 | 722 | 290 |
| Pre-tax Income | -24,629 | -30,070 | -15,151 | -20,410 | -25,092 |
| Net Income Continuous | -24,629 | -30,070 | -15,151 | -20,410 | -25,092 |
| Net Income | $-24,629 | $-30,070 | $-15,151 | $-20,410 | $-25,092 |
| EPS Basic Total Ops | -1.25 | -1.54 | -0.69 | -2.71 | -3.33 |
| EPS Basic Continuous Ops | -1.25 | -1.54 | -0.68 | -2.71 | -3.33 |
| EPS Diluted Total Ops | -1.25 | -1.54 | -0.69 | -2.71 | -3.33 |
| EPS Diluted Continuous Ops | -1.25 | -1.54 | -0.68 | -2.71 | -3.33 |
| EBITDA(a) | $-26,198 | $-31,168 | $-34,303 | $-20,711 | $-24,505 |